Regulations.gov document
Pulmonary-Allergy Drugs Advisory Committee
Notice · FDA-2012-N-0001 · posted Dec 14, 2012
Key facts
| Document ID | FDA-2012-N-0001-0151 |
|---|---|
| Title | Pulmonary-Allergy Drugs Advisory Committee |
| Document type | Notice |
| Subtype | Meeting |
| Agency | FDA |
| Docket | FDA-2012-N-0001 |
| Posted | Dec 14, 2012 |
| Federal Register citation | 77 FR 74486 |
| FR document number | 2012-30171 |
| Comment period opens | Dec 14, 2012 |
| Effective date | Dec 14, 2012 |
At a glance
- 1–9 Pages
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: